Precocious sexual development in a male toddler caused by unrecognized transdermal exposure to testosterone: case report and review of the literature.
Svetlana AzovaJoseph WolfsdorfPublished in: Journal of pediatric endocrinology & metabolism : JPEM (2021)
Despite the 2009 "black box" warning issued by the United States Food and Drug Administration (FDA) regarding potential consequences of transdermal testosterone exposure to women and children, this continues to be an important cause of sexual precocity in children. Children are often subjected to unnecessary and costly evaluation before this exposure is recognized, underscoring the importance of obtaining a thorough medical, family, and social history tailored to the differential diagnosis.